Keywords: ftc, ok, pfizer/warner-lambert, merger, demands, divestitures, federal
FTC OK for Pfizer/Warner-Lambert merger, but with demands for divestitures
Article | 20 June 2000
The US Federal Trade Commission has approved the $110 billion stock-swapmerger of Pfizer and Warner-Lambert, which creates a $300 million drugs giant ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
